Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, DC 20549


FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
 


Date of Report (Date of earliest event reported):   October 28, 2008
 
 

 
BOSTON SCIENTIFIC CORPORATION
(Exact name of registrant as specified in charter)
 
 
DELAWARE 
1-11083
04-2695240
(State or other jurisdiction of incorporation)
(Commission file number)
(IRS employer identification no.)
 
 
One Boston Scientific Place, Natick, Massachusetts
01760-1537
(Address of principal executive offices)
(Zip code)
 

Registrant’s telephone number, including area code:              (508) 650-8000
 
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the fling obligation of the registrant under any of the following provisions:

o  Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 
 


ITEM 1.01.
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
   
 
On October 28, 2008, our Board of Directors approved an amendment to and restatement of the Boston Scientific Corporation Deferred Compensation Plan (the “Plan”) in order to bring the Plan into compliance with Internal Revenue Code Section 409A and to make several technical and administrative changes.  A copy of the Plan, as amended and restated, is filed herewith as Exhibit 10.1.
 
 
 
 
ITEM 9.01. 
FINANCIAL STATEMENTS AND EXHIBITS.
   
Exhibit  No.
 Description
   
10.1
Boston Scientific Corporation Non-Employee Director Deferred Compensation Plan, as Amended and Restated, effective as of January 1, 2009.

 
 
 
 
 
 
 
 
SIGNATURE


Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
  BOSTON SCIENTIFIC CORPORATION  
     
       
Date:   October 31, 2008
By:
/s/ Lawrence J. Knopf  
   
Lawrence J. Knopf
  
   
Senior Vice President and Deputy General Counsel
  
       
 
 
 
 
 
 
 
 
 
 
 
 
 

 
EXHIBIT INDEX


                               

Exhibit  No. 
 Description
   
10.1
Boston Scientific Corporation Non-Employee Director Deferred Compensation Plan, as Amended and Restated, effective as of January 1, 2009.